In the United States, blood from corona19 curers sells for as much as tens of millions of won, the New York Times reported.
For developers of corona19 vaccines or therapies, some blood companies in the United States are making profits by selling donated blood at a high price, with blood samples desperately needed.
According to e-mails and documents confirmed by NYT, the bio-company, Canter BioConnect, is from March 31st to April 22nd. It takes a minimum of $ 350 to $ 40,000 in 1 ml (20 drops) of blood, and about $ 40,000 in our money. Sold for 50 million won.
The higher the antibody level in the blood, the higher the price.
It is known that the donor was paid an actual cost of $ 100, or approximately 125,000 won.
In addition, an Indian company that connects Canter BioConnect with buyers has sold blood samples for up to $ 50,000, or about 62 million won.
"I donated blood to Seattle's nonprofit clinic, and it's so sad that someone was making a profit," said Alesia Jenkins, who donated blood after being cured in Corona 19.
NYT noted that the infected person's bona fide profits from blood donated in good faith are subject to condemnation in the medical community, but some companies view the pandemic only as an opportunity to make big money.
Blood trade was mainly in the United States, but each UK research institute was also a major customer base.
The New York Times "Corona 19 complete blood, deal for tens of millions of won"
2020-05-03T20:53:44.335Z
In the United States, blood from corona19 curers sells for as much as tens of millions of won, the New York Times reported. For developers of corona19 vaccines or therapies, some blood companies in the United States are making profits by selling donated blood at a high price, with blood samples desperately needed.
Source: sbskr